By Catherine Eckford (European Pharmaceutical Review)2025-02-19T17:22:34
The research highlights potential for the technology to advance development of pharmaceutically relevant peptide amides as therapies.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-14T12:32:00Z
Sponsored by Thermo Fisher Scientific
2026-04-14T12:29:00Z
Sponsored by JRS Pharma, In association with Vetter Pharma
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-09-17T08:00:00
Sponsored by Mastercontrol
2025-06-11T13:00:00
Sponsored by Rapid Micro Biosystems
2025-10-08T07:00:00
Sponsored by Entegris
2025-09-19T15:52:00
Sponsored by Sanner, By Uwe Raupbach (Sanner)
2025-10-22T14:00:00
Sponsored by Bruker
Site powered by Webvision Cloud